Back to Anacor Homepage Developing Drug Candidates Through Boron Chemistry
Infinite Menus, Copyright 2006, OpenCube Inc. All Rights Reserved.
Learn more about the six clinical-stage products

By exploiting the advantages of our boron chemistry platform, we have discovered and advanced into clinical development several novel and proprietary boron-based product candidates that address attractive market opportunities.

[ View pipeline ]

Pipeline Graphic
New Releases

Monday, March 31, 2014 | Anacor Pharmaceuticals Announces First Patient Enrolled in Phase 3 Trial of AN2728 in Mild-to-Moderate Atopic Dermatitis
Wednesday, March 19, 2014 | Anacor Pharmaceuticals Appoints Paul L. Berns as Chief Executive Officer
Thursday, March 13, 2014 | Anacor Pharmaceuticals Reports 2013 Fourth Quarter and Year-End Financial Results
New Releases Graphic
Scientific Presentations

January 17-22, 2014 - Kohala Coast, HI

2014 Winter Clinical Dermatology Conference

November 13-17, 2013 - Washington, DC

ASTMH 62nd Annual Meeting

October 4-6, 2013 - Newport Beach, CA

Women’s & Pediatric Dermatology Seminar

May 8-11, 2013 - Edinburgh, Scotland

International Investigative Dermatology Meeting

April 25, 2013 - Emeryville, CA

World Malaria Day

October 14-18, 2012 - Dallas, TX

18th North American Regional ISSX

August 16-19, 2012 - Washington, DC

100th National American Podiatric Medical Association Annual Scientific Meeting